These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 18626549)
1. Bacille Calmette-Guerin immunotherapy of viral warts. Al-Mendalawi MD; Sharquie K Saudi Med J; 2008 Jul; 29(7):1068; author reply 1068. PubMed ID: 18626549 [No Abstract] [Full Text] [Related]
2. Immunotherapy in viral warts with intradermal Podder I; Bhattacharya S; Mishra V; Sarkar TK; Chandra S; Sil A; Pal S; Kumar D; Saha A; Shome K; Bandyopadhyay D; Das NK Indian J Dermatol Venereol Leprol; 2017; 83(3):411. PubMed ID: 27852999 [TBL] [Abstract][Full Text] [Related]
3. Size of tuberculin skin test reaction, bacille Calmette-Guérin vaccination and tuberculosis in children. Gendrel D; Chalumeau M; Moulin F Clin Infect Dis; 2005 Jun; 40(11):1703. PubMed ID: 15889377 [No Abstract] [Full Text] [Related]
4. Bacille Calmette-Guerin immunotherapy of viral warts. Sharquie KE; Al-Rawi JR; Al-Nuaimy AA; Radhy SH Saudi Med J; 2008 Apr; 29(4):589-93. PubMed ID: 18382805 [TBL] [Abstract][Full Text] [Related]
5. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis. Araujo Z; de Waard JH; de Larrea CF; Borges R; Convit J Vaccine; 2008 Oct; 26(44):5575-81. PubMed ID: 18723065 [TBL] [Abstract][Full Text] [Related]
6. The Al-Yassen AQ; Al-Maliki SK; Al-Asadi JN Sultan Qaboos Univ Med J; 2020 Aug; 20(3):e330-e336. PubMed ID: 33110649 [TBL] [Abstract][Full Text] [Related]
7. The role of a whole blood interferon-gamma assay for the detection of latent tuberculosis infection in Bacille Calmette-Guérin vaccinated children. Chun JK; Kim CK; Kim HS; Jung GY; Lee TJ; Kim KH; Kim DS Diagn Microbiol Infect Dis; 2008 Dec; 62(4):389-94. PubMed ID: 18990532 [TBL] [Abstract][Full Text] [Related]
8. Immunotherapy in cutaneous warts: comparative clinical Study between MMR vaccine, tuberculin, and BCG Vaccine. Shaker ESE; Doghim NN; Hassan AM; Musafa SS; Fawzy MM J Cosmet Dermatol; 2021 Aug; 20(8):2657-2666. PubMed ID: 33410249 [TBL] [Abstract][Full Text] [Related]
9. The effect of Bacille Calmette-Guerin (BCG) vaccination on intradermal tuberculin reactivity in Tasmania. Wood-Baker R; Walker D; Dargaville P Aust N Z J Med; 1997 Feb; 27(1):82-3. PubMed ID: 9079263 [No Abstract] [Full Text] [Related]
10. Age-specific cut-offs for the tuberculin skin test to detect latent tuberculosis in BCG-vaccinated children. Chan PC; Chang LY; Wu YC; Lu CY; Kuo HS; Lee CY; Huang LM; Chen CJ Int J Tuberc Lung Dis; 2008 Dec; 12(12):1401-6. PubMed ID: 19017449 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of bacille Calmette-Guérin immunotherapy predicted by expression of antigen-presenting molecules and chemokines. Videira PA; Calais FM; Correia M; Ligeiro D; Crespo HJ; Calais F; Trindade H Urology; 2009 Oct; 74(4):944-50. PubMed ID: 19428084 [TBL] [Abstract][Full Text] [Related]
12. Treatment of recalcitrant warts with Bacillus Calmette-Guérin: a promising new approach. Nofal A; Yosef A; Salah E Dermatol Ther; 2013; 26(6):481-5. PubMed ID: 24552412 [TBL] [Abstract][Full Text] [Related]
13. Re: The Bacillus Calmette-Guerin (BCG) Vaccine: Is it a better choice for the treatment of viral warts? Al-Mendalawi MD Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e141-e142. PubMed ID: 33777439 [No Abstract] [Full Text] [Related]
14. Sporotrichoid spread of locoregional bacille Calmette-Guerin infection following intralesional immunotherapy for verruca vulgaris in an immunocompetent adult. Patra S; Maninder K; Soumya N; Dinesh PA; Jai Kumar C Indian J Dermatol Venereol Leprol; 2023; 89(5):733-735. PubMed ID: 37317771 [No Abstract] [Full Text] [Related]
15. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy. Ayari C; LaRue H; Hovington H; Decobert M; Harel F; Bergeron A; Têtu B; Lacombe L; Fradet Y Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487 [TBL] [Abstract][Full Text] [Related]
16. Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guérin immunotherapy. Ahirwar DK; Mandhani A; Dharaskar A; Kesarwani P; Mittal RD BJU Int; 2009 Sep; 104(6):867-73. PubMed ID: 19338536 [TBL] [Abstract][Full Text] [Related]
17. The decline of tuberculosis in Yemen: evaluation based on two nationwide tuberculin surveys. Al-Absi A; Bassili A; Abdul Bary H; Barker A; Daniels M; Munim A; Seita A; Williams B; Dye C Int J Tuberc Lung Dis; 2009 Sep; 13(9):1100-5. PubMed ID: 19723398 [TBL] [Abstract][Full Text] [Related]
18. BCG vaccine for immunotherapy in warts: is it really safe in a tuberculosis endemic area? Daulatabad D; Pandhi D; Singal A Dermatol Ther; 2016 May; 29(3):168-72. PubMed ID: 26809285 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment of anogenital warts with single dose Bacillus Calmette Guerin vaccine without prior sensitization in tuberculosis endemic country: Two case report. Achdiat PA; Suwarsa O; Hidayat YM; Shafiee MN; Dwiyana RF; Gunawan H; Rowawi R; Johan R Hum Vaccin Immunother; 2023 Dec; 19(1):2187591. PubMed ID: 36942667 [TBL] [Abstract][Full Text] [Related]
20. An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder. Berglund RK; Savage CJ; Vora KC; Kurta JM; Cronin AM J Urol; 2008 Oct; 180(4):1297-300; discussion 1300. PubMed ID: 18707737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]